Orthofix Medical Inc. (NASDAQ:OFIX) Stock Holdings Increased by Geode Capital Management LLC

Geode Capital Management LLC grew its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 0.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 841,637 shares of the medical device company’s stock after buying an additional 2,448 shares during the period. Geode Capital Management LLC owned about 2.20% of Orthofix Medical worth $14,699,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Franklin Resources Inc. raised its stake in Orthofix Medical by 37.4% during the third quarter. Franklin Resources Inc. now owns 20,960 shares of the medical device company’s stock worth $337,000 after acquiring an additional 5,702 shares during the period. Barclays PLC raised its position in shares of Orthofix Medical by 38.8% during the 3rd quarter. Barclays PLC now owns 122,472 shares of the medical device company’s stock worth $1,912,000 after purchasing an additional 34,210 shares during the period. Kirr Marbach & Co. LLC IN acquired a new stake in shares of Orthofix Medical during the 4th quarter worth approximately $532,000. JPMorgan Chase & Co. lifted its holdings in shares of Orthofix Medical by 480.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 84,379 shares of the medical device company’s stock worth $1,318,000 after purchasing an additional 69,848 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in Orthofix Medical during the 4th quarter valued at approximately $1,003,000. Institutional investors and hedge funds own 89.76% of the company’s stock.

Analyst Ratings Changes

OFIX has been the subject of a number of analyst reports. StockNews.com raised shares of Orthofix Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $24.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, Roth Mkm reissued a “buy” rating and issued a $22.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $23.33.

Orthofix Medical Trading Up 0.5 %

Shares of NASDAQ OFIX opened at $13.03 on Monday. The business has a fifty day simple moving average of $16.25 and a 200-day simple moving average of $17.17. The company has a quick ratio of 1.11, a current ratio of 2.39 and a debt-to-equity ratio of 0.25. Orthofix Medical Inc. has a 12 month low of $12.08 and a 12 month high of $20.73. The company has a market cap of $508.46 million, a price-to-earnings ratio of -4.16 and a beta of 0.99.

Insider Transactions at Orthofix Medical

In related news, insider Jorge Andres Cedron sold 3,816 shares of the firm’s stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $13.31, for a total transaction of $50,790.96. Following the transaction, the insider now owns 42,500 shares of the company’s stock, valued at approximately $565,675. This trade represents a 8.24 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Lucas Vitale sold 4,287 shares of Orthofix Medical stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total transaction of $71,164.20. Following the completion of the sale, the insider now owns 135,317 shares of the company’s stock, valued at $2,246,262.20. This trade represents a 3.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 9,242 shares of company stock valued at $141,710 over the last quarter. Company insiders own 2.60% of the company’s stock.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.